瑞财经 王敏7月24日,港交所文件显示,江苏中慧元通生物科技股份有限公司-B(以下简称“中慧生物”)更新港交所招股书,中信证券及招银国际为其保荐机构。据悉,这是继中慧生物于2025年1月23日递表失效后的再一次申请;2025年6月25日其获中国证监会国际司境外发行上市备案通知书,拟发行不超过1.38亿股境外上市普通股。招股书显示,中慧生物成立于2015年,致力于人用疫苗的研发及产业化,聚焦于未被...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.